PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsurinary retention
MeSH D016055 - urinary retention
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014555:Urination disorders
6 Companies
3 Drugs
$
Success rate
D016055: 
Urinary retention
55 Companies
8 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaDoxazosin Doxazosin  2001-01-12   
Prazosin Prazosin  1988-09-12   
Terazosin Terazosin  2000-05-18   
MylanPrazosin Prazosin  1989-05-16   
Terazosin Terazosin  2000-02-11   
SandozTerazosin Terazosin  1998-12-31   
PfizerPrazosin Minipress  1982-01-01   
Polythiazide, Prazosin Minizide  1982-01-01   
Aurobindo PharmaDoxazosin Doxazosin  2000-10-19   
Prazosin Prazosin  2023-03-31   
Dr Reddys LaboratoriesNeostigmine Neostigmine Methylsulfate  2018-07-10   
Zydus TherapeuticsDoxazosin Doxazosin  2017-07-07   
ApotexDoxazosin Doxazosin  2000-10-18   
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
43%
3/7
Phase 3
58%
7/12
Approved: 6Overall Success rate: 25%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Pfizer
Prazosin
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use